CYP2C19 Genotype-Guided Antiplatelet Therapy and 30-Day Outcomes After Percutaneous Coronary Intervention

被引：9
|
作者：
Williams, Alexis K. [1 ]
Klein, Melissa D. [2 ]
Martin, Jesse [1 ]
Weck, Karen E. [4 ]
Rossi, Joseph S. [2 ,3 ]
Stouffer, George A. [2 ,3 ]
Lee, Craig R. [1 ,3 ]
机构：
[1] Univ N Carolina, Eshelman Sch Pharm, Div Pharmacotherapy & Expt Therapeut, Chapel Hill, NC USA
[2] Univ N Carolina, Sch Med, Div Cardiol, Chapel Hill, NC USA
[3] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC USA
[4] Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Chapel Hill, NC USA
来源：
CIRCULATION-GENOMIC AND PRECISION MEDICINE | 2019年 / 12卷 / 02期
关键词：
cardiovascular diseases; clopidogrel; pharmacogenetics; precision medicine; IMPLEMENTATION;
D O I：
10.1161/CIRCGEN.119.002441
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：97 / 99
页数：3
相关论文
共 50 条
  • [41] Implementation and evaluation of a CYP2C19 genotype-guided antiplatelet therapy algorithm in high-risk coronary artery disease patients.
    Lee, John Andrew
    Reed, Brent N.
    Plitt, David C.
    Cicci, Jonathan D.
    Tasca, Kristen E.
    Weck, Karen E.
    Lee, Craig R.
    Stouffer, George A.
    PHARMACOTHERAPY, 2014, 34 (10): : E221 - E221
  • [42] Genotype-Guided Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Interventions
    Zhou, Y.
    Harada, S.
    Armstead, A. R.
    Coshatt, G. M.
    Sankaranarayanan, A.
    Fuller, J. S.
    Sayers, S. A.
    Blair, C.
    Dillon, C.
    Brott, B. C.
    Alsip, J. A.
    Limdi, N. A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (06): : 845 - 845
  • [43] Results of genotype-guided antiplatelet therapy in patients who undergone percutaneous coronary intervention with stent
    Sanchez-Ramos, Jesus
    Lucia Davila-Fajardo, Cristina
    Toledo Frias, Pablo
    Diaz Villamarin, Xando
    Javier Martinez-Gonzalez, Luis
    Martinez Huertas, Susana
    Burillo Gomez, Francisco
    Caballero Borrego, Juan
    Bautista Paves, Alicia
    Marin Guzman, Ma Carmen
    Ramirez Hernandez, Jose Antonio
    Correa Vilches, Concepcion
    Cabeza Barrera, Jose
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 225 : 289 - 295
  • [44] COST-EFFECTIVENESS OF THE CYP2C19 GENOTYPE-GUIDED ANTIPLATELET THERAPY COMPARED TO UNIVERSAL USE OF TICAGRELOR OR CLOPIDOGREL IN QATAR
    AlMukdad, S.
    Elewa, H.
    Al-Badriyeh, D.
    VALUE IN HEALTH, 2020, 23 : S96 - S97
  • [45] Economic Evaluations of CYP2C19 Genotype-Guided Antiplatelet Therapy Compared to the Universal Use of Antiplatelets in Patients With Acute Coronary Syndrome: A Systematic Review
    AlMukdad, Sawsan
    Elewa, Hazem
    Al-Badriyeh, Daoud
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2020, 25 (03) : 201 - 211
  • [46] COST-EFFECTIVENESS OF CYP2C19 GENOTYPE-GUIDED DUAL ANTIPLATELET THERAPY FOR ACUTE MINOR ISCHEMIC STROKE OR TIA
    Kremers, F.
    Venema, E.
    Cras, T.
    Burke, J.
    Roozenbeek, B.
    Dippel, D.
    INTERNATIONAL JOURNAL OF STROKE, 2021, 16 (2_SUPPL) : 19 - 19
  • [47] Frequency and clinical outcomes of CYP2C19 genotype-guided escalation and de-escalation of antiplatelet therapy in a real-world clinical setting
    Martin, Jesse
    Williams, Alexis K.
    Klein, Melissa D.
    Sriramoju, Vindhya B.
    Madan, Shivanshu
    Rossi, Joseph S.
    Clarke, Megan
    Cicci, Jonathan D.
    Cavallari, Larisa H.
    Weck, Karen E.
    Stouffer, George A.
    Lee, Craig R.
    GENETICS IN MEDICINE, 2020, 22 (01) : 160 - 169
  • [48] EVALUATION OF CARDIOVASCULAR OUTCOMES IN PATIENTS WITH DIABETES FOLLOWING IMPLEMENTATION OF CYP2C19 GENOTYPE-GUIDED ANTIPLATELET THERAPY IN A REAL-WORLD SETTING.
    Mulrenin, I.
    Gower, M.
    Williams, A.
    Weck, K.
    Rossi, J.
    Stouffer, G.
    Lee, C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S51 - S52
  • [49] Genotype-guided antiplatelet therapy for acute coronary syndrome percutaneous coronary intervention patients: A new standard of care?
    Ashley, Kellan E.
    Hillegass, William B.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2021, 97 (05) : 795 - 796
  • [50] It is urgent to evaluate the efficacy and safety of genotype-guided antiplatelet therapy in patients after percutaneous coronary intervention in East Asian
    Xu, Liang
    Yu, Cheng Xin
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 345 : 39 - 39
12345